General Information of Drug (ID: DMVRH9C)

Drug Name
Lomefloxacin Drug Info
Synonyms
LFLX; Lomefloxacine; Lomefloxacino; Lomefloxacinum; Lomefloxacine [French]; Lomefloxacino [Spanish]; Lomefloxacinum[Latin]; SC 4711; SC 47111A; DM 10 (bactericide); DM-10; Lomefloxacin (USAN); Maxaquin (TN); Maxaquin (hydrochloride); Okacyn (TN); SC-4711; SC-47111A; Uniquin (TN); Lomefloxacin [USAN:BAN:INN]; NY-198 (hydrochloride); SC-47111 (hydrochloride); SC-47111B (mesylate); (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride
Therapeutic ClassAntibiotics
Cross-matching ID
PubChem CID
3948
ChEBI ID
CHEMBL116278
CAS Number
CAS 98079-51-7
TTD Drug ID
D02KOF
VARIDT Drug ID
DR00507
INTEDE Drug ID
DR0968

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Complement and coagulation cascades 1.93 2.07e-2 76/85 (89.41%) CFD;C3;SERPING1;...
ECM-receptor interaction 1.83 2.59e-2 80/88 (90.91%) LAMB1;CD36;SDC4;...
Nicotine addiction 1.83 2.07e-2 32/40 (80%) GABRP;GABRE;GABRB3;...
Lysine degradation 1.77 4.92e-2 51/63 (80.95%) SUV39H1;MECOM;ALDH7A1;...
Adherens junction 1.76 4.77e-2 63/71 (88.73%) MET;SNAI2;CTNNA2;...
Parkinson disease -1.80 4.79e-2 176/249 (70.68%) ATP5F1A;NDUFA4L2;KIF5B;...
Ribosome -1.96 4.79e-3 113/158 (71.52%) RPL6;RPL24;RPL5;...
Oxidative phosphorylation -2.23 0.00e+0 93/133 (69.92%) ATP5PO;ATP6V1E1;ATP6V0E1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HuH-7 CVCL_0336 Homo sapiens 10uM 72H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 24H